SCHEMBL6269458

SCHEMBL6269458

CC(=O)Oc1ccc(C)c(C)c1C

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN1 P18031 2/20 0.57
ACHE P22303 3/20 0.50
HTT P42858 1/20 0.49
GBA1 P04062 1/20 0.46
POLB P06746 1/20 0.46
KDM4E B2RXH2 3/20 0.46
ALDH1A1 P00352 3/20 0.46
TSHR P16473 3/20 0.46
GAA P10253 1/20 0.46
RAB9A P51151 1/20 0.46
NCEH1 Q6PIU2 1/20 0.44
CFD P00746 1/20 0.44
LMNA P02545 1/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
MAPK1 P28482 1/20 0.43
KMT2A Q03164 1/20 0.43
ESR1 P03372 1/20 0.42
ITGB3 P05106 1/20 0.42
ITGA2B P08514 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12723861 0.91 ACHE (0.57) PTPN1ACHEHTTGBA1POLB
SCHEMBL7947809 0.88 POLB (0.51) PTPN1ACHEHTTGBA1POLB
SCHEMBL9328943 0.88 PTPN1 (0.62) PTPN1ACHEHTTGBA1POLB
SCHEMBL729665 0.84 NCEH1 (0.46) PTPN1ACHEHTTGBA1POLB
SCHEMBL29580838 0.84 NCEH1 (0.46) PTPN1ACHEHTTGBA1POLB
SCHEMBL7390252 0.83 ACHE (0.47) PTPN1ACHEHTTGBA1POLB
SCHEMBL6973179 0.83 NCEH1 (0.44) PTPN1ACHEHTTGBA1POLB
SCHEMBL983662 0.83 PTPN1 (0.45) PTPN1ACHEGBA1POLBKDM4E
SCHEMBL10546986 0.83 MAPK1 (0.52) PTPN1ACHEHTTGBA1POLB
SCHEMBL8949855 0.82 PTPN1 (0.53) PTPN1ACHEHTTPOLBKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1049466-B1 CARBONIC ANHYDRASE INHIBITOR FOR INCREASING OXYGEN TENSION IN THE OPTIC NERVE AND RETINA STEFANSSON EINAR (IS) 2005-12-07 EP claimed
US-20240186579-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE INCLUDING THE SAME Prime Planet Energy & Solutions, Inc. (JP) 2024-06-06 US disclosed
EP-4379885-A1 NONAQUEOUS ELECTROLYTE SOLUTION AND ELECTRICITY STORAGE DEVICE INCLUDING THE SAME Prime Planet Energy & Solutions, Inc. (JP) 2024-06-05 EP disclosed
EP-1268390-B1 A PROCESS FOR PREPARING TRIMETHYLHYDROQUINONE DIACETATE AND TRIMETHYLHYDROQUINONE DEGUSSA (DE) 2004-02-18 EP disclosed
EP-1268390-A1 A PROCESS FOR PREPARING TRIMETHYLHYDROQUINONE DIACETATE AND TRIMETHYLHYDROQUINONE Degussa AG (DE) 2003-01-02 EP disclosed
US-6350897-B2 OXIDATION OF 2,2,6-TRIMETHYLCYCLOHEXANE-1,4-DIONE; SULFONATION; ACYLATION DEGUSSA AG (DE) 2002-02-26 US disclosed
US-20020004619-A1 Process for preparing trimethylhydroquinone diacetate and trimethylhydroquinone DEGUSSA AG (DE) 2002-01-10 US disclosed
WO-2001077058-A1 A PROCESS FOR PREPARING TRIMETHYLHYDROQUINONE DIACETATE AND TRIMETHYLHYDROQUINONE DEGUSSA AG (DE) 2001-10-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020004619-A1 Process for preparing trimethylhydroquinone diacetate and trimethylhydroquinone SULT2A1, MSMO1, TET1 PTPN1 4207/4885ACHE 3711/4885HTT 2377/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.